JT Lew, PharmD, MBA, managed care pharmacist at MultiCare Health System, spoke to the impacts of processes such as prior authorization and step therapy requirements in the realm of multiple sclerosis ...

Discover Biogen's groundbreaking patent for assessing PML risk in MS patients through JC Virus antibody detection, enhancing treatment safety and efficacy.

Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

The totality of data from Sanofi clinical trials indicates that Tolebrutinib may target inflammation thought to contribute to ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

Dr. Barot joins an already accomplished team of medical experts at ADIA Nutrition, bringing with him a wealth of knowledge ...

Gaps in access to care persist for US patients with MS and impact HRQOL to a large extent. Improving access to care for patients with MS should be prioritized.

[5] Pinke KH, et al. Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy? Neurotherapeutics. 2020 Jan;17(1):218-234. [6] Brown MA, Weinberg RB. Mast Cells and ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

After missing primary endpoints in relapsing forms of MS, tolebrutinib has proved its efficacy in secondary progressive MS ...

Early physiotherapy for nerve injuries is crucial for brain retraining, functional independence; neuro-rehabilitation involves multidisciplinary approach for recovery.